Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, January 17, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Michael Wiederhorn Maintained (CHE) at Buy with Increased Target to $625 on, Jan 17th, 2024
Michael Wiederhorn of Oppenheimer, Maintained "Chemed Corporation" (CHE) at Buy with Increased Target from $590 to $625 on, Jan 17th, 2024.
Michael has made no other calls on CHE in the last 4 months.
There is 1 other peer that has a rating on CHE. Out of the 1 peers that are also analyzing CHE, 0 agree with Michael's Rating of Hold.
This is the rating of the analyst that currently disagrees with Michael
- Ben Hendrix of "RBC Capital" Maintained at Buy with Increased Target to $604 on, Monday, October 30th, 2023
